Scott D. Ramsey
Ph.D., University of Pennsylvania, 1994.
M.D., University of Iowa, 1990.
B.S., University of Iowa, 1983.
Health Related Quality of Life
Internship and Residency in Internal Medicine
A Retrospective Evaluation of Patterns of Care for American Indian and Alaska Native Men with Elevated Prostate Specific Antigen
Linking Cancer Registries with Medicaid to Measure Cancer Treatment and Outcomes
Promoting Cancer Screening Among American Indians through Art and Storytelling
Physician and Navigator Discussion Guides in Prostate Cancer: A Controlled Trial
A Study of Cancer Diagnosis as a Risk Factor for Personal Bankruptcy
Blood Product Use among Persons with Myelodysplastic Syndrome
American College of Physicians
American Society of Clinical Oncology
Cancer Intervention and Surveillance Network
International Health Economics Association
International Society for Pharmacoeconomic and Outcomes Research
Society for Medical Decision Making
Honors and Awards
1997-1998, Howard Temin Career Development Award, National Cancer Institute
1996-1997, Robert Wood Johnson Faculty Support Award, University of Washington
1995-1996, Robert H. Williams Award, American Federation for Clinical Research
1994-1995, Cecile Lehman Mayer Research Award recipient, American College of Chest Physicians
1991-1992, John and Oral Sebelin Award - Outstanding Student in Internal Medicine, College of Medicine, University of Iowa
1989-1990, University Research Foundation support grant, Wharton School, University of Pennsylvania
1987-1988, Dean's Scholarship, Wharton School, University of Pennsylvania
1986-1987, Kellogg Washington Health Policy Fellowship, Wharton School, University of Pennsylvania
1983-1984, University of Iowa Certificate of Achievement, University of Iowa
1982-1983, Chester A. Phillips Scholarship, College of Medicine, University of Iowa
1982-1983, Mortar Board, University of Iowa, University of Iowa
1982-1983, Omicron Delta Kappa, Omicron Delta Kappa--national leadership society,, University of Iowa
1982-1983, BeBeta Gamma Sigma, Beta Gamma Sigma--honorary fraternity in business, University of Iowa
1980-1981, University of Iowa Merit Award, College of Medicine, University of Iowa
2001-2006, Associate Professor, University of Washington, School of Medicine, Medicine, General Internal Medicine
2000-2005, Associate Member, Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences
1997-2000, Assistant Professor, University of Washington, School of Medicine, Medicine, General Internal Medicine
1997-2000, Assistant Professor, University of Washington, School of Public Health and Community Medicine, Health Services
1997-2000, Joint Assistant Member, Fred Hutchinson Cancer Research Center, Public Health Sciences Division
1995-1998, Staff Physician, VA Puget Sound Health Care System, Seattle Divison
1995-1997, Acting Assistant Professor, University of Washington, Health Sciences
1995-2000, Director, University of Washington, Center for Cost and Outcomes Research, Clinical Economics
1995-1997, Acting Assistant Professor, University of Washington, School of Medicine, Medicine, General Internal Medicine
1994-1995, Chief Medical Resident, University of Washington, Medical Center, Medicine
1994-1995, Acting Instructor, University of Washington, School of Medicine, Medicine
1993-1994, Fellow, University of Washington, School of Medicine, Medicine, General Internal Medicine
1990-1993, University of Washington, Internal Medicine
Comparative Effectiveness Research in Cancer Genomics and Precision Medicine: Current Landscape and Future Prospects.. Journal of the National Cancer Institute.. 2013.
Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics.. Medical decision making : an international journal of the Society for Medical Decision Making. 33(4):463-71.. 2013.
Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.. Journal of oncology practice / American Society of Clinical Oncology. 9(1):42-50.. 2013.
Antimicrobial prophylaxis and outpatient management of Fever and neutropenia in adults treated for malignancy: american society of clinical oncology clinical practice guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(6):794-810.. 2013.
lung cancer screening with low-dose computed tomography.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(4):366-7.. 2013.
Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.. Genetics in medicine : official journal of the American College of Medical Genetics.. 2012.
The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007).. Contemporary clinical trials. 33(6):1117-23.. 2012.
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(14):1608-14.. 2012.
Patterns of blood product use among patients with myelodysplastic syndrome.. Vox sanguinis. 102(4):331-337.. 2012.
A Comparison of Approaches for Association Studies of Polymorphisms and Colorectal Cancer Risk.. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.. 2012.
New-Onset Treatment-Dependent Diabetes Mellitus and Hyperlipidemia Associated with Atypical Antipsychotic Use in Older Adults without Schizophrenia or Bipolar Disorder.. Journal of the American Geriatrics Society. 60(3):474-479.. 2012.
Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process.. Journal of comparative effectiveness research. 1(4):359-370.. 2012.
Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 15(5):716-23.. 2012.
Complementary and alternative medicine use among newly diagnosed prostate cancer patients.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20(1):65-73.. 2012.
Is distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer? The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 28(1):54-62.. 2012.
Systematic review of comparative effectiveness data for oncology orphan drugs.. The American journal of managed care. 18(1):47-62.. 2012.
Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(2):267-75.. 2012.
Proof or principle? On economic modeling to guide genomic testing in metastatic colorectal cancer. Journal of the National Cancer Institute. 104(23):1779-80.. 2012.
End-of-life Care in the ICU: Can We Simultaneously Increase Quality and Reduce Costs? American journal of respiratory and critical care medicine.. 2012.
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.. Genetics in medicine : official journal of the American College of Medical Genetics.. 2012.
Health insurer policies toward risk-stratified colorectal cancer screening: a survey of health plan medical directors.. Journal of insurance medicine (New York, N.Y.). 43(2):92-101.. 2012.
A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(6):836-45.. 2011.